Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.68 |
| ▸ | CA1 | P00915 | 1/20 | 0.63 |
| ▸ | CA2 | P00918 | 1/20 | 0.63 |
| ▸ | CA9 | Q16790 | 1/20 | 0.63 |
| ▸ | APP | P05067 | 2/20 | 0.62 |
| ▸ | MITF | O75030 | 1/20 | 0.60 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.60 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.60 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | NPC1 | O15118 | 2/20 | 0.54 |
| ▸ | RAB9A | P51151 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | NPY1R | P25929 | 1/20 | 0.54 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | RELA | Q04206 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27001618 | 0.98 | MAOB (0.66) | MAOBCA1CA2CA9APP | |
| SCHEMBL4659168 | 0.88 | MAOB (0.78) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL9812779 | 0.87 | APP (0.57) | MAOBCA1CA2CA9APP | |
| SCHEMBL20208913 | 0.86 | ALOX5 (0.57) | MAOBCA1CA2CA9APP | |
| SCHEMBL5768216 | 0.84 | MAOB (0.72) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL31105656 | 0.84 | MAOB (0.71) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL731363 | 0.84 | MAOB (0.71) | MAOBCA1CA2CA9ALOX5 | |
| SCHEMBL7818265 | 0.82 | APP (0.74) | MAOBCA2APPMITFNPC1 | |
| SCHEMBL14900924 | 0.82 | APP (0.68) | MAOBAPPMITFNPC1RAB9A | |
| SCHEMBL6676481 | 0.81 | MAOB (0.65) | MAOBCA1CA2CA9MITF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 493 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101711151-B | Stabilization of UV-sensitive active ingredients | CIBA HOLDING INC | 2013-12-18 | — | — | CN | claimed |
| US-6828044-B2 | Blue light emitting; 2-(3- or 4- n,n-substituted-amino-phenyl)-benzofuran derivative; performance; static or motion imaging device | EASTMAN KODAK COMPANY | 2004-12-07 | — | — | US | claimed |
| CN-1170522-C | Use of bis (resorcinyl) triazine derivatives in cosmetics | �������⻯ѧƷ�ع�����˾ | 2004-10-13 | — | — | CN | claimed |
| WO-2004040669-A1 | DOPANT IN AN ELECTROLUMINESCENT DEVICE | EASTMAN KODAK COMPANY (US) | 2004-05-13 | — | — | WO | claimed |
| US-20040081853-A1 | Dopant in an electroluminescent device | EASTMAN KODAK COMPANY | 2004-04-29 | — | — | US | claimed |
| US-12569414-B2 | Sunscreen compositions containing porous metal oxide spheres | BASF SE (DE) | 2026-03-10 | — | — | US | disclosed |
| US-20250099345-A1 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | BASF SE (DE) | 2025-03-27 | — | — | US | disclosed |
| US-20250090429-A1 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | BASF SE (DE) | 2025-03-20 | — | — | US | disclosed |
| CN-119487025-A | Amine compound, and organic electroluminescent element, electronic device and electronic element each containing the same | 保土谷化学工业株式会社 | 2025-02-18 | — | — | CN | disclosed |
| EP-4465949-A1 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | BASF SE (DE) | 2024-11-27 | — | — | EP | disclosed |
| EP-4465950-A1 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | BASF SE (DE) | 2024-11-27 | — | — | EP | disclosed |
| CN-118695840-A | UV filter composition comprising closed cell metal oxide particles | 巴斯夫欧洲公司 | 2024-09-24 | — | — | CN | disclosed |
| EP-0613893-A1 | Benzofuran derivatives and the use thereof as stabilizers against UV radiations | 3V SIGMA S.p.A (IT) | 1994-09-07 | — | — | EP | disclosed |
| US-5332568-A | Benzofuranylphenyl substituted, cosmetics | 3V INC. (US) | 1994-07-26 | — | — | US | disclosed |
| US-5302704-A | For dyeing polyamide fibers; colorfastness | CIBA-GEIGY CORPORATION (US) | 1994-04-12 | — | — | US | disclosed |
| EP-0570845-A1 | S-Triazine derivatives having light-protecting action | 3V SIGMA S.p.A (IT) | 1993-11-24 | — | — | EP | disclosed |
| EP-0527704-A2 | Dyestuffs, process for their preparation and the use thereof | CIBA-GEIGY AG (CH) | 1993-02-17 | — | — | EP | disclosed |
| US-4284787-A | Process for the preparation of 1,2,3-triazoles substituted in the 2-position | BAYER AKTIENGESELLSCHAFT (DE) | 1981-08-18 | — | — | US | disclosed |
| EP-0004897-B1 | PROCESS FOR THE PREPARATION OF 1,2,3 TRIAZOLES SUBSTITUTED IN THE 2-POSITION | BAYER AG (DE) | 1981-03-18 | — | — | EP | disclosed |
| EP-0004897-A2 | Process for the preparation of 1,2,3 triazoles substituted in the 2-position | BAYER AG (DE) | 1979-10-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250099345-A1 | UV FILTER COMPOSITIONS COMPRISING CLOSED-CELL METAL OXIDE PARTICLES | SUN2, ERCC4, XPA | MAOB 2280/4885CA1 1543/4885CA2 1375/4885 |
| US-20250090429-A1 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | ERCC4, SUN2, ERCC5 | MAOB 1427/4885CA1 2649/4885CA2 1722/4885 |
| US-12569414-B2 | Sunscreen compositions containing porous metal oxide spheres | RAD50, CTSA, MCM7 | MAOB 1735/4885CA1 3673/4885CA2 2263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.